坏死性下垂
免疫学
生物
细胞因子
炎症
肿瘤坏死因子α
细胞激素风暴
程序性细胞死亡
医学
细胞凋亡
病理
生物化学
传染病(医学专业)
疾病
2019年冠状病毒病(COVID-19)
作者
Rajendra Karki,Bhesh Raj Sharma,Shraddha Tuladhar,Evan P. Williams,Lillian Zalduondo,Parimal Samir,Min Zheng,Balamurugan Sundaram,Balaji Banoth,R. K. Subbarao Malireddi,Patrick Schreiner,Geoffrey Neale,Peter Vogel,Richard J. Webby,Colleen B. Jonsson,Thirumala‐Devi Kanneganti
出处
期刊:Cell
[Elsevier]
日期:2020-11-19
卷期号:184 (1): 149-168.e17
被引量:1121
标识
DOI:10.1016/j.cell.2020.11.025
摘要
COVID-19 is characterized by excessive production of pro-inflammatory cytokines and acute lung damage associated with patient mortality. While multiple inflammatory cytokines are produced by innate immune cells during SARS-CoV-2 infection, we found that only the combination of TNF-α and IFN-γ induced inflammatory cell death characterized by inflammatory cell death, PANoptosis. Mechanistically, TNF-α and IFN-γ co-treatment activated the JAK/STAT1/IRF1 axis, inducing nitric oxide production and driving caspase-8/FADD-mediated PANoptosis. TNF-α and IFN-γ caused a lethal cytokine shock in mice that mirrors the tissue damage and inflammation of COVID-19, and inhibiting PANoptosis protected mice from this pathology and death. Furthermore, treating with neutralizing antibodies against TNF-α and IFN-γ protected mice from mortality during SARS-CoV-2 infection, sepsis, hemophagocytic lymphohistiocytosis, and cytokine shock. Collectively, our findings suggest that blocking the cytokine-mediated inflammatory cell death signaling pathway identified here may benefit patients with COVID-19 or other infectious and autoinflammatory diseases by limiting tissue damage/inflammation.
科研通智能强力驱动
Strongly Powered by AbleSci AI